[Press Release] Healthcare Target ③ Successfully Localizes Stem Cell Extraction Device “Smart Mcell 2”
[Healthcare Target] ③ Successful Localization of Stem Cell Extraction Device “Smart Mcell 2” Miracell Wins the Ministry of Food and Drug Safety Commissioner’s Award (Innovative Medical Sector)Smart Mcell 2, World-Leading Cell Viability and Recovery RatesAlso Selected as a National Innovative Company By Kim Young-hwan [Edaily Reporter Kim Young-hwan] Stem cell specialist Miracell Co., Ltd. received the Minister of Food and Drug Safety Award (Innovative Medical Category) at the Edaily Global Healthcare Awards. This recognition recognizes the company’s technological achievements in researching and developing cell extraction systems to establish stem cell treatments in Korea. Miracell successfully developed and domestically produced the “Smart M-Cell 2” stem cell extraction equipment and kit, which boast world-leading cell viability and recovery rates. Smart M-Cell 2 is a cutting-edge “bone marrow and blood stem cell manufacturing” system that extracts hematopoietic stem cells (CD34+) from blood and mesenchymal stem cells from bone marrow using biological drug manufacturing technology. According to experimental results from Seoul National University Bundang Hospital, Smart M-Cell 2 demonstrated cell counts and viability rates comparable to or exceeding those of the world’s leading product, SmartPrep from the United States. Approximately 2.9 billion cells can be separated and extracted in one session, achieving a cell viability rate of 80-98%. Another notable feature is its closed system, which prevents air contact and prevents cell deformation. Smart Mcell 2 is currently used in major hospitals in Korea. In May, Miracell was selected as a “National Representative Innovative Company” by the government. The National Representative Innovative Company program evaluates promising companies possessing patents and core technologies in various fields and selects companies that will lead innovation-driven growth industries. In February, Miracell also received NET (No. 179) certification from the Ministry of Health and Welfare for its “Bone Marrow Blood Stem Cell Extraction Device Including a Centrifuge for Selective Separation.”
K-Healthcare Shines Amid COVID-19: “Hopefully This Will Be an Opportunity to Take It to the Next Level”
K-Healthcare Shines Amid COVID-19: “Hopefully This Will Be an Opportunity to Take It to the Next Level” The Edaily Global Healthcare Awards Ceremony was held on the 19th. Miracell Co., Ltd. and Rainbow & Nature Korea received the MFDS Minister of Food and Drug Safety Award. [Edaily Reporter Kim Young-hwan] “I hope this will contribute significantly to the development of Korea’s medical and healthcare industries.I also hope this will serve as an opportunity to elevate the level of our country’s medical industry.” Shin Hyun-soon, CEO of Miracell Co., Ltd. (left), poses for a commemorative photo after receiving the Minister of Food and Drug Safety Award in the Innovative Medical Device category at the 8th Edaily Global Healthcare Awards held at the KG Harmony Hall in the KG Tower in Jung-gu, Seoul on the afternoon of the 19th. (Photo = Reporter Lee Young-hoon) At the 8th Edaily Global Healthcare Awards ceremony held at the KG Harmony Hall on the first basement level of the KG Tower in Jung-gu, Seoul on the 19th, the chair of the judging panel, Seo Yoo-seong, Vice President of Medical Affairs and Director of Soonchunhyang University Medical Center, explained the significance of the awards ceremony. Ten medical institutions and related companies received awards at the event. The Edaily Global Healthcare Awards, held this year for the 8th time, aims to discover and foster outstanding medical institutions and related companies in the healthcare industry, enhance their global competitiveness, and provide consumers with sound standards for choosing healthcare services.Hosted by Edaily, the event was sponsored by the Ministry of Health and Welfare, the National Assembly Health and Welfare Committee, the Ministry of Food and Drug Safety, and the Korea Medical Devices Industry Association. Stem cell specialist Miracell Co., Ltd. received the Minister of Food and Drug Safety Award in the Innovative Medical Device category in recognition of its successful domestic development and localization of the “SMART M-CELL2” and kit. SMART M-CELL2 is a stem cell extraction device that offers world-class cell viability and recovery rates. In May, Miracell was also selected as a “National Representative Innovative Company” by the government.